Revenio Group Oyj (REVXF)
OTC
Closed
Sep 25, 2026
Day's Range
13.5452 wk Range
13.54Overview - REVXF - Revenio Group Oyj
Key Statistics
Valuation
Enterprise Value
852.46M
P/E (Trailing)
‪23.78‬
PEG Ratio
‪-0.27‬
Price / Sales (TTM)
‪3.83‬
Price / Book
‪2.83‬
EV / EBITDA
‪36.48‬
Profitability
Gross Margin
‪64.63%‬
Profit Margin
‪10.54%‬
Operating Margin
‪6.04%‬
Return on Assets
‪3.56%‬
Return on Equity
‪10.32%‬
Ownership
Shares Outstanding
26.60M
Float
27.96M
Held by Insiders
‪9.67%‬
Held by Institutions
‪51.65%‬
Price stats
Beta
‪0.87‬
50-Day Avg
‪16.41‬
200-Day Avg
‪21.52‬
Dividends
Payout Ratio
‪67.85%‬
Frequency
Annual
Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - REVXF - Revenio Group Oyj
Peers - REVXF - Revenio Group Oyj
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - REVXF - Revenio Group Oyj
About
Revenio Group Oyj is a Finnish health technology company and a global leader in ophthalmological devices and software solutions. It develops and commercializes effective, easy-to-use screening devices for detecting significant public health diseases, particularly in eye care. Its flagship offerings under the iCare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
